NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Metabolic Imaging of Neurological Disease
Metabolic Imaging of Neurological Disease

NCT06900244

Enrolling By InvitationN/A

Sponsor: University of Oxford

Conditions: Multiple Sclerosis

Countries: United Kingdom

Multiple Sclerosis is a chronic condition that shows changes in the way that the brain consumes sugar. It is also known that there are a number of metabolic and inflammatory sequelae following a transient ischemic attack/stroke (hereby referred to collectively as 'stroke'). This study will use a powerful new technology ('hyperpolarised magnetic resonance imaging') to detect these changes in the brains of people with multiple sclerosis and Clinically Isolated Syndrome (CIS) or following a stroke when compared to a group of healthy volunteers. It will be undertaken at the University of Oxford, and each participant will undergo up to 4 scans over the course of three years.

Eligibility overview

Sex: ALL

Age: to 99 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Diagnosis of MS or stroke

Exclusion Criteria:

\-
Locations (1)
  • Oxford, United Kingdom